Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-03 19:16 | 2022-11-02 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $362.07 | 6,131 | $2,219,851 | 103,357,679 | 0.0% |
| 2022-10-24 23:10 | 2022-10-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $338.32 | 161,936 | $54,786,641 | 103,363,810 | -0.2% |
| 2022-10-20 21:17 | 2022-10-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $335.48 | 3,547 | $1,189,933 | 103,525,746 | 0.0% |
| 2022-10-19 21:56 | 2022-10-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $334.03 | 12,042 | $4,022,377 | 103,529,293 | 0.0% |
| 2022-10-18 22:45 | 2022-10-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $335.41 | 79,624 | $26,706,630 | 103,541,335 | -0.1% |
| 2022-10-17 20:02 | 2022-10-14 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $333.95 | 3,187 | $1,064,307 | 103,620,959 | 0.0% |
| 2022-10-14 00:36 | 2022-10-12 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $333.50 | 400 | $133,400 | 103,624,146 | 0.0% |
| 2022-10-11 23:09 | 2022-10-10 | LLY | ELI LILLY & Co | Weems Alonzo | Officer; EVP, ERM & CECO | Pharmaceutical Preparations | SALE | $326.23 | 656 | $214,007 | 6,950 | -8.6% |
| 2022-10-07 22:08 | 2022-10-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $334.54 | 149,264 | $49,934,077 | 103,624,546 | -0.1% |
| 2022-09-29 20:56 | 2022-09-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $335.07 | 101,631 | $34,053,652 | 103,773,810 | -0.1% |
| 2022-09-06 23:22 | 2022-09-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $301.00 | 1,000 | $301,000 | 5,274 | -15.9% |
| 2022-08-16 23:06 | 2022-08-12 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $304.19 | 656 | $199,549 | 62,857 | +1.1% |
| 2022-08-12 23:34 | 2022-08-10 | LLY | ELI LILLY & Co | Weems Alonzo | Officer; SVP, ERM & CECO | Pharmaceutical Preparations | SALE | $304.50 | 656 | $199,752 | 8,136 | -7.5% |
| 2022-07-29 18:43 | 2022-07-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $332.85 | 89,458 | $29,776,516 | 103,875,441 | -0.1% |
| 2022-07-27 17:26 | 2022-07-26 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $332.52 | 1,601 | $532,371 | 103,964,899 | 0.0% |
| 2022-07-18 20:50 | 2022-07-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $332.76 | 17,310 | $5,760,013 | 103,966,500 | 0.0% |
| 2022-07-07 19:03 | 2022-07-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $330.28 | 177,243 | $58,539,304 | 103,983,810 | -0.2% |
| 2022-06-29 18:31 | 2022-06-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $329.01 | 900 | $296,109 | 104,161,053 | 0.0% |
| 2022-06-28 20:54 | 2022-06-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $329.05 | 41,857 | $13,772,837 | 104,161,953 | 0.0% |
| 2022-06-27 20:45 | 2022-06-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $324.31 | 215,000 | $69,726,328 | 104,203,810 | -0.2% |
| 2022-06-24 20:36 | 2022-06-23 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $311.05 | 205,000 | $63,764,758 | 104,418,810 | -0.2% |
| 2022-06-23 21:50 | 2022-06-22 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $306.84 | 210,000 | $64,435,602 | 104,623,810 | -0.2% |
| 2022-06-03 01:43 | 2022-06-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $313.44 | 1,000 | $313,440 | 6,274 | -13.7% |
| 2022-05-31 21:44 | 2022-05-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $318.98 | 200,000 | $63,796,660 | 104,833,810 | -0.2% |
| 2022-05-27 17:58 | 2022-05-26 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $311.27 | 178,390 | $55,526,813 | 105,033,810 | -0.2% |
| 2022-05-26 18:40 | 2022-05-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $308.95 | 41,610 | $12,855,268 | 105,212,200 | 0.0% |
| 2022-05-25 18:37 | 2022-05-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $305.98 | 100,000 | $30,597,960 | 105,253,810 | -0.1% |
| 2022-05-24 19:51 | 2022-05-23 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $302.73 | 118,856 | $35,981,669 | 105,353,810 | -0.1% |
| 2022-05-19 17:08 | 2022-05-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $302.00 | 700 | $211,400 | 105,472,666 | 0.0% |
| 2022-05-18 20:11 | 2022-05-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $302.26 | 19,683 | $5,949,342 | 105,473,366 | 0.0% |
| 2022-05-17 18:03 | 2022-05-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $302.53 | 80,761 | $24,432,997 | 105,493,049 | -0.1% |
| 2022-04-11 21:26 | 2022-04-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $310.79 | 139,045 | $43,213,796 | 105,573,810 | -0.1% |
| 2022-04-08 22:20 | 2022-04-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $309.82 | 70,955 | $21,982,987 | 105,712,855 | -0.1% |
| 2022-04-07 19:44 | 2022-04-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $300.92 | 51,851 | $15,603,018 | 105,783,810 | 0.0% |
| 2022-04-06 21:35 | 2022-04-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $293.86 | 113,756 | $33,428,338 | 105,835,661 | -0.1% |
| 2022-04-05 21:31 | 2022-04-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $293.15 | 39,393 | $11,548,137 | 105,949,417 | 0.0% |
| 2022-04-04 21:34 | 2022-04-01 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $292.38 | 165,376 | $48,352,784 | 105,988,810 | -0.2% |
| 2022-03-31 19:51 | 2022-03-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $292.03 | 2,500 | $730,075 | 106,154,186 | 0.0% |
| 2022-03-30 23:37 | 2022-03-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $292.39 | 4,341 | $1,269,254 | 106,156,686 | 0.0% |
| 2022-03-29 21:14 | 2022-03-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $292.16 | 7,538 | $2,202,264 | 106,161,027 | 0.0% |
| 2022-03-22 22:41 | 2022-03-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $292.43 | 35,245 | $10,306,604 | 106,168,565 | 0.0% |
| 2022-03-21 20:12 | 2022-03-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $288.18 | 210,000 | $60,518,367 | 106,203,810 | -0.2% |
| 2022-03-18 18:48 | 2022-03-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $283.80 | 220,000 | $62,435,450 | 106,413,810 | -0.2% |
| 2022-03-17 23:12 | 2022-03-17 | LLY | ELI LILLY & Co | Jonsson Patrik | Officer; SVP&Pres, LLY Imm, LLY USA&CCO | Pharmaceutical Preparations | SALE | $277.20 | 673 | $186,556 | 31,362 | -2.1% |
| 2022-03-16 18:44 | 2022-03-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $274.96 | 220,075 | $60,511,866 | 106,633,810 | -0.2% |
| 2022-03-15 21:13 | 2022-03-14 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $269.39 | 173,085 | $46,626,918 | 106,853,885 | -0.2% |
| 2022-03-14 22:02 | 2022-03-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $269.05 | 21,840 | $5,875,986 | 107,026,970 | 0.0% |
| 2022-03-11 20:04 | 2022-03-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $266.45 | 184,982 | $49,287,547 | 107,048,810 | -0.2% |
| 2022-03-10 20:39 | 2022-03-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $266.52 | 20,018 | $5,335,147 | 107,233,792 | 0.0% |
| 2022-03-07 21:27 | 2022-03-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $262.24 | 210,000 | $55,070,946 | 107,253,810 | -0.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.